Why should population attributable fractions be periodically recalculated? An example from cardiovascular risk estimation in southern Europe.
OBJECTIVE
To determine the effect of age and study period on coronary heart disease (CHD) risk attributable to cardiovascular risk factors.


METHODS
A cohort of cardiovascular disease (CVD)-free randomly participants from Girona (Spain) aged 35-74 years recruited in 1995 and 2000 and followed for an average of 6.9 years. A survey conducted in the same area in 2005 was also used for the analysis. Smoking, hypertension, diabetes, sedentary lifestyle, obesity, total cholesterol > or = 240 mg/dl, low-density lipoprotein (LDL) cholesterol > or = 160 mg/dl, and high-density lipoprotein cholesterol <40 mg/dl were the risk factors considered. The composite end-point included myocardial infarction, angina pectoris, and CHD death.


RESULTS
LDL cholesterol had the highest potential for CHD prevention between 35 and 74 years [42% (95% Confidence Interval: 23,58)]. The age-stratified analysis showed that the population attributable risk (PAF) for smoking was 64% (30,80) in subjects < 55 years; for those > or = 55 years, the PAF for hypertension was 34% (1,61). The decrease observed between 1995 and 2005 in the population's mean LDL cholesterol level reduced that PAF in all age groups.


CONCLUSIONS
Overall, LDL cholesterol levels had the highest potential for CHD prevention. Periodic PAF recalculation in different age groups may be required to adequately monitor population trends.
Grau
María
M
Epidemiology and Cardiovascular Genetics, Program of Research on Inflammatory and Cardiovascular Disorders, Institut Municipal d'Investigació Mèdica, 08003 Barcelona, Spain.
Subirana
Isaac
I
Elosua
Roberto
R
Fitó
Montserrat
M
Covas
Maria-Isabel
MI
Sala
Joan
J
Masiá
Rafael
R
Ramos
Rafel
R
Solanas
Pascual
P
Cordon
Ferran
F
Nieto
F Javier
FJ
Marrugat
Jaume
J
D000328:Adult; D017677:Age Distribution; D000368:Aged; D003327:Coronary Disease / Q000453:epidemiology / Q000517:prevention & control; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006937:Hypercholesterolemia / Q000453:epidemiology* / Q000517:prevention & control; D006973:Hypertension / Q000453:epidemiology; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000401:mortality* / Q000517:prevention & control*; D009765:Obesity / Q000453:epidemiology; D016491:Peripheral Vascular Diseases / Q000453:epidemiology / Q000517:prevention & control; D015995:Prevalence; D012307:Risk Factors; D057185:Sedentary Behavior; D012907:Smoking / Q000453:epidemiology; D013030:Spain / Q000453:epidemiology